USPTO Approves Vireo Health’s Patent Application for Less Harmful Tobacco Products Infused with Cannabis
The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Vireo Health’s (CSE: VREO) patent application titled, “Tobacco Products with Cannabinoid Additives and Methods for Reducing the Harm Associated with Tobacco Use.”
Vireo’s patent application is in line with its efforts to create cannabinoid additives for use in tobacco products that will help reduce irritation, inflammation and carcinogenicity.
“This patent is a component of our strategy to disrupt the tobacco industry and help save lives,” said Chief Executive Officer, Kyle Kingsley, M.D. “As a physician, I am passionate about finding ways to use cannabis to reduce the harmful effects of tobacco. We look forward to collaborating with research institutions and tobacco companies committed to developing less harmful tobacco products.”
{{cta(‘8bda15e4-5341-4195-a3c9-920630e5666d’)}}
These cannabis-based additives can be used in cigarettes, cigars, pipe tobacco, and smokeless tobacco products. The company hopes to develop cannabis-based additives that can be used to reduce the health risks posed by tobacco use.
Smoking, Vaping and Cannabinoids
Vaping is fast becoming a popular alternative for smokers. And most of today’s CBD products include CBD vape juices that offers smokers a healthier alternative to smoking but also gives them the opportunity to enjoy the many health benefits of CBD.
Vireo’s application for the use of cannabinoid additives for use in tobacco products is certainly new. This is because cannabinoids are directly used with tobacco products which is certainly different from vaping. This is certainly exciting since this an entirely new product. And if proven successful, Vireo can stand to benefit as the sole source for this cannabinoid-based product.
About Vireo Health International, Inc.
Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries.
The Company currently has operations in ten states including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.
USPTO Approves Vireo Health’s Patent Application for Less Harmful Tobacco Products Infused with Cannabis
